C&O completed the clinical trial of Rabeprazole Sodium for Injection in 2011 and will be the first to be approved for production and marketing this year. After that, the product will be available for investment on a provincial basis nationwide. As a
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account 
Mobile page